Vitiligo Repigmentation: How Skin Color Returns and the Latest Breakthroughs

Last updated: November 2026. Reviewed against American Academy of Dermatology (AAD) guidance, FDA information and published research.

Repigmentation means color returning to skin that vitiligo has turned white. For many people it is the main goal of treatment. This guide explains how repigmentation happens, what it looks like, why some areas respond better than others, how long it takes, and the latest breakthroughs in getting color back.

For an overview of every treatment, see our guide to vitiligo treatment options.

Can Vitiligo Be Reversed?

There is no cure for vitiligo yet, but treatment can bring color back to many patches. Vitiligo happens when the immune system attacks melanocytes, the cells that make skin pigment. Treatment works in two ways: it calms the immune attack, and it encourages remaining pigment cells to grow and spread into white areas.

How Repigmentation Happens

The main source of new color is the hair follicle. Research shows that hair follicles hold a reserve of pigment stem cells that the immune attack often leaves untouched. With treatment, these cells wake up, multiply and move up into the surrounding skin. Pigment cells at the edge of a patch, and a few that survive inside it, also help.

This is why patches with white hairs tend to respond poorly to light therapy: when the hair has lost its color too, the follicle’s pigment reserve is usually gone.

Vitiligo Repigmentation Stages and Patterns

Color rarely returns evenly. Dermatologists describe a few common patterns:

Many people first notice small freckle-like dots inside a white patch. Over months, these dots can spread and merge as more color fills in.

Why Some Areas Repigment Better Than Others

Areas with many hair follicles usually respond best. According to the AAD, the face and neck respond most to light therapy, while the lips, fingertips and toes respond least to vitiligo treatments in general. Hairless skin, such as the palms, soles, fingertips and lips, has no follicle reserve, so color has to come mostly from the patch edges. Research reviews note that full color may not return in these areas.

How Long Does Repigmentation Take?

Repigmentation is slow. Most treatments need months before results are clear, and full color may take longer or may not return in hard-to-treat areas. In the clinical trials for ruxolitinib cream, more people had good results at 52 weeks than at 24 weeks, and the FDA-approved labeling notes that a satisfactory response may take more than 24 weeks.

Ruxolitinib Cream: The First FDA-Approved Repigmentation Therapy

In July 2022 the FDA approved ruxolitinib cream 1.5% (Opzelura) as the first treatment for repigmentation in nonsegmental vitiligo, for people 12 and older. It is applied twice a day to up to 10% of the body. Ruxolitinib is a JAK inhibitor, a medicine that blocks signals the immune system uses to attack pigment cells.

In the phase 3 trials:

• At week 24, about 30% of people using the cream regained at least 75% of the color on their face, compared with about 8% to 13% using a cream without medicine.
• At week 52, about 50% reached that level.
• About 30% regained at least 90% of facial color by week 52.

The cream is approved for ages 12 and up. For younger children, talk with a dermatologist about which treatments are suitable.

Oral JAK Inhibitors: The Next Frontier

Ruxolitinib cream is meant for smaller areas. For people with more widespread vitiligo, JAK inhibitor pills are the biggest breakthrough in development:

• Upadacitinib (Rinvoq): approved for vitiligo in the European Union in July 2026 and under FDA review. In the Viti-Up phase 3 trials, 28% to 33% of patients regained at least 75% of facial color at week 48. Among those who stayed on treatment, this rose to 47% to 55% by week 76, and 40% to 43% had at least half their total vitiligo area improve.
• Ritlecitinib (Litfulo): already FDA-approved for severe alopecia areata. In July 2026 Pfizer reported that two phase 3 vitiligo trials met their main goals for facial and total body repigmentation at week 52. Pfizer plans to file for FDA approval for adults.
• Povorcitinib: in two phase 3 trials in adults, about 19% of patients regained at least 75% of facial color at week 52, compared with 3% to 7% on placebo. Incyte plans to file in the first half of 2027.
• Baricitinib (Olumiant): FDA-approved for other conditions, but not for vitiligo.

No JAK pill is FDA-approved for vitiligo yet. For details on each medicine, side effects and the FDA boxed warning that applies to JAK inhibitors, read our guide to JAK inhibitors for vitiligo.

Afamelanotide: A Different Approach

Afamelanotide (Scenesse) works differently from JAK inhibitors. Instead of calming the immune system, it copies a natural hormone (alpha-MSH) that tells pigment cells to make more pigment. It is FDA-approved for a rare light-sensitivity condition called erythropoietic protoporphyria, but it is not approved for vitiligo anywhere in the world.

Its maker, Clinuvel, is testing it in a phase 3 trial (CUV105) of more than 200 people aged 12 and older with skin types III to VI, most of them enrolled in the United States. Patients receive afamelanotide implants plus narrowband UVB light therapy, or light therapy alone, for 20 weeks. First results are expected in the second half of 2026. A second phase 3 trial (CUV107) of 300 patients, also comparing afamelanotide plus light therapy with light therapy alone, is set to begin in the second half of 2026.

Combination Approaches

Pairing treatments can help color return faster. The AAD notes that light therapy works slowly on its own, so dermatologists may prescribe it along with a cream. Afamelanotide is also being studied together with light therapy. Because the ruxolitinib cream label advises limiting sun exposure, combining it with light therapy is a decision for your dermatologist.

Keeping Color After It Returns

Restored color does not always last. According to the AAD, about 40% of people see some color loss within a year of stopping treatment. To help prevent this, dermatologists often prescribe a maintenance plan, such as applying a medicated cream a few times a week.

Challenges and Unmet Needs

• Repigmentation takes months, and results vary from person to person.
• Hands, feet, lips, fingertips and toes remain the hardest areas to treat.
• Patches with white hairs respond less well.
• Color can fade after stopping treatment, so long-term care is often needed.

The new pills and combination approaches aim to improve results for people with widespread or hard-to-treat vitiligo.

Vitiligo Care in North Carolina

Trillium Clinic Dermatology sees patients with vitiligo at our offices in Chapel Hill, Smithfield and Burlington, North Carolina. Our dermatologists can assess your vitiligo, explain which treatments may help restore color, and talk through new options as they become available. Learn more about vitiligo or read about how JAK inhibitors are changing vitiligo care.

Schedule an appointment at one of our North Carolina offices.